Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats.

Urbanowicz W, Sogni P, Moreau R, Tazi KA, Barriere E, Poirel O, Martin A, Guimont MC, Cazals-Hatem D, Lebrec D.

Gut. 2004 Dec;53(12):1844-9.

2.

Innate immunity via Toll-like receptors and Nod proteins.

Athman R, Philpott D.

Curr Opin Microbiol. 2004 Feb;7(1):25-32. Review.

PMID:
15036136
3.

Coagulation disorders in patients with cirrhosis and severe sepsis.

Plessier A, Denninger MH, Consigny Y, Pessione F, Francoz C, Durand F, Francque S, Bezeaud A, Chauvelot-Moachon L, Lebrec D, Valla DC, Moreau R.

Liver Int. 2003 Dec;23(6):440-8.

PMID:
15002397
4.

Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial.

Hou MC, Lin HC, Liu TT, Kuo BI, Lee FY, Chang FY, Lee SD.

Hepatology. 2004 Mar;39(3):746-53.

PMID:
14999693
5.

Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey.

Foreman MG, Mannino DM, Moss M.

Chest. 2003 Sep;124(3):1016-20.

PMID:
12970032
6.

Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis.

Riordan SM, Skinner N, Nagree A, McCallum H, McIver CJ, Kurtovic J, Hamilton JA, Bengmark S, Williams R, Visvanathan K.

Hepatology. 2003 May;37(5):1154-64.

PMID:
12717397
7.

Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.

Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA.

Hepatology. 2003 May;37(5):1043-55.

PMID:
12717385
8.

Liver in sepsis and systemic inflammatory response syndrome.

Szabo G, Romics L Jr, Frendl G.

Clin Liver Dis. 2002 Nov;6(4):1045-66, x. Review.

PMID:
12516206
9.

Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients.

Rayes N, Seehofer D, Hansen S, Boucsein K, Müller AR, Serke S, Bengmark S, Neuhaus P.

Transplantation. 2002 Jul 15;74(1):123-7.

PMID:
12134110
10.

Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients.

Zwaveling JH, Maring JK, Klompmaker IJ, Haagsma EB, Bottema JT, Laseur M, Winter HL, van Enckevort PJ, TenVergert EM, Metselaar HJ, Bruining HA, Slooff MJ.

Crit Care Med. 2002 Jun;30(6):1204-9.

PMID:
12072669
11.

Activation of endothelial cell protease activated receptor 1 by the protein C pathway.

Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W.

Science. 2002 Jun 7;296(5574):1880-2.

12.

Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis.

Bauer TM, Fernández J, Navasa M, Vila J, Rodés J.

J Hepatol. 2002 Apr;36(4):501-6.

PMID:
11943421
13.

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Fernández J, Navasa M, Gómez J, Colmenero J, Vila J, Arroyo V, Rodés J.

Hepatology. 2002 Jan;35(1):140-8.

PMID:
11786970
14.

Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding.

Vivas S, Rodriguez M, Palacio MA, Linares A, Alonso JL, Rodrigo L.

Dig Dis Sci. 2001 Dec;46(12):2752-7.

PMID:
11768269
15.

Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia.

Ottesen LH, Harry D, Frost M, Davies S, Khan K, Halliwell B, Moore K.

Free Radic Biol Med. 2001 Sep 15;31(6):790-8.

PMID:
11557317
16.

Low levels of protein C are associated with poor outcome in severe sepsis.

Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR.

Chest. 2001 Sep;120(3):915-22.

PMID:
11555529
17.

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, Colloredo-Mels G, Corigliano P, Fornaciari G, Marenco G, Pistarà R, Salvagnini M, Sangiovanni A.

Dig Liver Dis. 2001 Jan-Feb;33(1):41-8.

PMID:
11303974
18.

Efficacy and safety of recombinant human activated protein C for severe sepsis.

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group.

N Engl J Med. 2001 Mar 8;344(10):699-709.

19.

Bacterial translocation of enteric organisms in patients with cirrhosis.

Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taurá P, Fuster J, García-Valdecasas JC, Lacy A, Suárez MJ, Rimola A, Rodés J.

J Hepatol. 2001 Jan;34(1):32-7.

PMID:
11211904
20.

Supplemental Content

Support Center